Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Desflurane vs Sevoflurane on Remifentanil Requirement in Spine Surgery
NCT06123624Unknown
- Sponsor
- Ajou University School of Medicine
- Start
- Nov 2023
- Primary completion
- Aug 2024
- Modality
- Allosteric Modulators
01
Overview
Randomised trial of desflurane in herniated disc, spinal cord injury (SCI) and meningioma (2 arms), sponsored by Ajou University School of Medicine. Primary endpoint: Remifentanil requirement up to 3 hours. Status: unknown.
02
Drugs
desflurane
03
Conditions
herniated discspinal cord injury (SCI)meningioma
Beyond the preview
Go deeper on NCT06123624.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06123624.